Davenport & CO LLC Catalyst Biosciences, Inc. Transaction History

Davenport & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.91 - $4.16 $54,054 - $247,104	-59,400 Closed	0 $0
Q3 2021 Oct 14, 2021	SELL	$3.78 - $5.18 $37,800 - $51,800	-10,000 Reduced 14.41%	59,400 $244,000
Q2 2021 Jul 28, 2021	BUY	$4.1 - $5.33 $27,879 - $36,244	6,800 Added 10.86%	69,400 $301,000
Q1 2021 Apr 28, 2021	BUY	$4.93 - $7.15 $17,255 - $25,025	3,500 Added 5.92%	62,600 $316,000
Q4 2020 Jan 13, 2021	BUY	$4.55 - $7.29 $268,905 - $430,839	59,100 New	59,100 $373,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.